Ainos, Inc. revenue
Ainos, Inc.'s revenue was $124,157 in fiscal 2025, up 499.0% on the year before. Since fiscal 2010 ($5,150) it has grown at a compound 25.5% a year. Over the last twelve months it was $13,600.
Revenue history
| Fiscal year | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 | 58 | 1 | 0 | 0 | 0 | 251 | 78 | 12 | 17 | 595 | 3,520 | 122 | 21 | 124 | 14 |
| Growth on the year before | — | +>999% | −99.1% | −100.0% | — | — | — | −69.0% | −84.9% | +41.2% | +>999% | +492.0% | −96.5% | −83.0% | +499.0% | — |
| Gross profit | 2 | 54 | 0 | — | — | — | 191 | 13 | 3 | 5 | 410 | 1,405 | −254 | −32 | 103 | 11 |
| Gross margin | 42.9% | 92.5% | 60.0% | — | — | — | 76.0% | 16.5% | 25.2% | 31.9% | 69.0% | 39.9% | — | — | 82.9% | 78.7% |
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Ainos, Inc. | $13,600 | -87.7% | -83.2% |
| Cuprina Holdings (cayman) LTD | $38,204 | 5.6% | — |
| Heartsciences Inc. | $4,519 | -64.2% | — |
| Phaos Technology Holdings (cayman) Ltd | $102,806 | -18.2% | — |
| Pavmed Inc. | $112,000 | -89.0% | -49.6% |
| Nexalin Technology, Inc. | $217,155 | 24.2% | -30.6% |
Compare with peers
- Cuprina Holdings (cayman) LTD revenue
- Heartsciences Inc. revenue
- Phaos Technology Holdings (cayman) Ltd revenue
- Pavmed Inc. revenue
- Nexalin Technology, Inc. revenue
Head to head: AIMD vs CUPRAIMD vs HSCSAIMD vs POAS
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies